Autoimmune, Inflammatory-Focused Biotech Odyssey Files for IPO

Odyssey Therapeutics Inc. filed for a US initial public offering, joining a growing pool of drug developers seeking to advance public listing plans amid robust investor demand for biotech stocks....

Redirecting to full article...